A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases
A Multi-centre Real-world Non-interventional Observational Study to Explore Prognoses of the Patients With Non-small Cell Lung Cancer Complicated With Oligometastases
Sponsor: LinkDoc Technology (Beijing) Co. Ltd.
Listed as NCT03427541, this observational or N/A phase trial focuses on Non Small Cell Lung Cancer and remains ongoing. Sponsored by LinkDoc Technology (Beijing) Co. Ltd., it has been updated 7 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Mar 2020 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Mar 2020 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Recruiting NA
First recorded
Dec 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- LinkDoc Technology (Beijing) Co. Ltd.
- Tang-Du Hospital
For direct contact, visit the study record on ClinicalTrials.gov .